At OncoFirm Diagnostics, we are transforming the future of rapid cancer diagnostics through next-generation lateral flow assay (LFA) technology. Our proprietary rapid tests are designed for early detection of multiple cancers, leveraging newly identified antigens and highly specific cancer biomarkers linked to disease progression. By combining scientific innovation with user-friendly formats, we deliver accurate, fast, and accessible screening tools for healthcare providers worldwide.*
OncoFirm™ Electronic Reader cassette reader* (detailed information coming soon)… Cutting-Edge Digital Cancer Diagnostics Solutions Lateral Flow Electronic Reader (LFER) technology is an advanced diagnostic tool used to enhance and quantify…
OncoScreen-CEA Rapid Test for Carcinoembryonic Antigen (CEA) – Colorectal, Breast, Lung, and Pancreatic Cancer Screening Overview:OncoScreen-CEA is a rapid diagnostic test developed by OncoFirm Diagnostics for the detection and monitoring…
OncoScreen-PSA Rapid Test for Prostate-Specific Antigen (PSA) Detection Overview:OncoScreen-PSA is a fast, reliable, and easy-to-use rapid test for the detection of elevated Prostate-Specific Antigen (PSA) levels—an important biomarker in the…
OncoMultiDx Multiplex Rapid Test for Multi-Cancer Screening in a Single Assay Overview:OncoMultiDx is OncoFirm Diagnostics’ most advanced lateral flow assay, designed to detect multiple cancer types from a single sample—providing…
OncoScreen-L Rapid Test Panel for Early Lung Cancer Detection Overview:OncoScreen-L is a cutting-edge rapid diagnostic panel developed by OncoFirm Diagnostics, designed to support the early detection of lung cancer in…
OncoScreen-B Rapid Test for Breast and Ovarian Cancer Detection Overview:OncoScreen-B is an advanced rapid diagnostic test developed by OncoFirm Diagnostics for the early detection of breast and ovarian cancers. Powered…
OncoScreen-R: Rapid test for colorectal and pancreatic cancers. OncoScreen-R Rapid Test for Colorectal and Pancreatic Cancer Detection Overview:OncoScreen-R is a high-performance lateral flow rapid test developed by OncoFirm Diagnostics, designed…